Association of the mutational composition in metastases and cancer-specific survival in our cohort indicated significantly worse cancer-specific survival probability for patients with metastases harbouring multiple somatic drivers and VHL wildtype alleles compared to PBRM1-, SETD2-, and VHL monodrivers. Here, SETD2 is linked to cancer.